Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TM2 domain containing 1 pseudogene is a human genomic sequence closely related to the TM2 domain containing 1 (TM2D1) gene, which encodes a beta-amyloid peptide-binding protein structurally related to the G protein-coupled receptor superfamily[1][7]. However, as a **pseudogene**, ENSG00000244652 does not encode a functional protein product and is generally considered non-functional by standard definitions[2][5][8][11]. Pseudogenes like this can arise from gene duplication or retrotransposition events and typically do not produce protein, nor do they have direct therapeutic or biomarker relevance under current knowledge[2][5][8]. **Key context:** - The functional TM2D1 gene encodes a protein involved in beta-amyloid peptide binding and G protein signaling and has been studied in the context of Alzheimer’s disease[1][7]. - The **pseudogene** variant, such as ENSG00000244652, lacks evidence of protein-coding potential and direct functional or disease relevance[2][5][8][11]. If a functional target or therapeutic relevance is sought, use "TM2 domain containing 1" (TM2D1, ENSG00000162604), **not the pseudogene**.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TM2 domain containing 1 pseudogene.